$2.48
-0.38-13.29%
Last update: 12:03 PM
15 minutes delayed
Comments
Loading...
AEON Biopharma
AEONAMEX
want to know what
the Bulls & Bears Say?
AEON Biopharma (AMEX:AEON) Stock, Analyst Ratings, Price Targets, Forecasts
AEON Biopharma Inc has a consensus price target of $6 based on the ratings of 1 analysts. The high is $6 issued by HC Wainwright & Co. on July 10, 2024. The low is $6 issued by HC Wainwright & Co. on July 10, 2024. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on July 10, 2024, May 30, 2024, and May 15, 2024, respectively. With an average price target of $6 between HC Wainwright & Co., there's an implied 141.94% upside for AEON Biopharma Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
1calculated from analyst ratings
Analyst Ratings for AEON Biopharma
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 07/10/2024 | Buy Now | 141.94% | HC Wainwright & Co. | Douglas Tsao | $6 → $6 | Reiterates | Buy → Buy | Get Alert |
| 05/30/2024 | Buy Now | 141.94% | HC Wainwright & Co. | Douglas Tsao | $6 → $6 | Reiterates | Buy → Buy | Get Alert |
| 05/15/2024 | Buy Now | 141.94% | HC Wainwright & Co. | Douglas Tsao | $18 → $6 | Maintains | Buy | Get Alert |
| 05/06/2024 | Buy Now | 625.81% | HC Wainwright & Co. | Douglas Tsao | → $18 | Reiterates | Buy → Buy | Get Alert |
| 04/17/2024 | Buy Now | 625.81% | HC Wainwright & Co. | Douglas Tsao | → $18 | Reiterates | Buy → Buy | Get Alert |
| 08/18/2023 | Buy Now | 625.81% | HC Wainwright & Co. | Douglas Tsao | → $18 | Initiates | → Buy | Get Alert |
FAQ
What is the target price for AEON Biopharma (AEON) stock?
The latest price target for AEON Biopharma (AMEX:AEON) was reported by HC Wainwright & Co. on July 10, 2024. The analyst firm set a price target for $6.00 expecting AEON to rise to within 12 months (a possible 141.94% upside). 6 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for AEON Biopharma (AEON)?
The latest analyst rating for AEON Biopharma (AMEX:AEON) was provided by HC Wainwright & Co., and AEON Biopharma reiterated their buy rating.
When was the last upgrade for AEON Biopharma (AEON)?
There is no last upgrade for AEON Biopharma
When was the last downgrade for AEON Biopharma (AEON)?
There is no last downgrade for AEON Biopharma.
When is the next analyst rating going to be posted or updated for AEON Biopharma (AEON)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of AEON Biopharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for AEON Biopharma was filed on July 10, 2024 so you should expect the next rating to be made available sometime around July 10, 2025.
Is the Analyst Rating AEON Biopharma (AEON) correct?
While ratings are subjective and will change, the latest AEON Biopharma (AEON) rating was a reiterated with a price target of $6.00 to $6.00. The current price AEON Biopharma (AEON) is trading at is $2.48, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.